JP2018518455A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018518455A5 JP2018518455A5 JP2017555213A JP2017555213A JP2018518455A5 JP 2018518455 A5 JP2018518455 A5 JP 2018518455A5 JP 2017555213 A JP2017555213 A JP 2017555213A JP 2017555213 A JP2017555213 A JP 2017555213A JP 2018518455 A5 JP2018518455 A5 JP 2018518455A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- inhibitor
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2015901423A AU2015901423A0 (en) | 2015-04-20 | Therapeutic antibodies and uses thereof | |
| AU2015901423 | 2015-04-20 | ||
| PCT/AU2016/000136 WO2016168885A1 (en) | 2015-04-20 | 2016-04-20 | Therapeutic antibodies and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018518455A JP2018518455A (ja) | 2018-07-12 |
| JP2018518455A5 true JP2018518455A5 (enExample) | 2019-05-30 |
| JP7063623B2 JP7063623B2 (ja) | 2022-05-09 |
Family
ID=57142773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017555213A Active JP7063623B2 (ja) | 2015-04-20 | 2016-04-20 | 治療用抗体およびその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11198738B2 (enExample) |
| EP (1) | EP3285805B1 (enExample) |
| JP (1) | JP7063623B2 (enExample) |
| KR (1) | KR102739664B1 (enExample) |
| CN (1) | CN107847593B (enExample) |
| AU (1) | AU2016250900B2 (enExample) |
| CA (1) | CA2983311A1 (enExample) |
| SG (1) | SG11201708624YA (enExample) |
| WO (1) | WO2016168885A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2014409558B2 (en) * | 2014-10-23 | 2021-08-12 | Minomic International Ltd. | Monoclonal anti-GPC-1 antibodies and uses thereof |
| WO2018199318A1 (ja) | 2017-04-28 | 2018-11-01 | 国立大学法人高知大学 | 抗ｇｐｃ－１抗体 |
| CN111954532A (zh) * | 2018-04-13 | 2020-11-17 | 上海交通大学医学院附属瑞金医院 | 杂芳基酰胺类化合物的抗肿瘤多药耐药性、治疗癌症的用途和蛋白质-药物分子复合物 |
| EA202192033A1 (ru) * | 2019-01-22 | 2021-10-21 | Клемсон Юниверсити Рисерч Фаундейшн | Антитела к эластину и способы их применения |
| WO2020154150A1 (en) * | 2019-01-22 | 2020-07-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | High affinity monoclonal antibodies targeting glypican-1 and methods of use |
| CN112175090B (zh) * | 2019-07-03 | 2024-04-26 | 深圳市雅臣智能生物工程有限公司 | 一种人溶菌酶结合物及其制备方法和应用 |
| CN110893236A (zh) * | 2019-10-09 | 2020-03-20 | 中山大学 | 溶酶体靶向的抗体药物偶联物及其应用 |
| CN111187350A (zh) * | 2019-12-30 | 2020-05-22 | 西安英创生物技术有限公司 | 一种与磷脂酰肌醇蛋白聚糖-1结合的抗原结合蛋白 |
| WO2021251903A1 (en) * | 2020-06-09 | 2021-12-16 | Temasek Life Sciences Laboratory Limited | Automated disease detection system |
| IT202200021546A1 (it) * | 2022-10-19 | 2024-04-19 | Centro Di Riferimento Oncologico Di Aviano | Anticorpo monoclonale anti-GPC1, suoi usi terapeutici e diagnostici |
| WO2024119233A1 (en) * | 2022-12-09 | 2024-06-13 | Carina Biotech Pty Ltd | Methods for diagnosing and treating ovarian cancer |
| WO2025202359A1 (en) * | 2024-03-27 | 2025-10-02 | Adcendo Aps | Anti-gpc1 antibodies and uses thereof |
| TW202543672A (zh) | 2024-03-27 | 2025-11-16 | 丹麥商阿德森多私人有限公司 | 抗gpc1抗體及其用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5622836A (en) * | 1989-05-24 | 1997-04-22 | The University Of Sydney | Monoclonal antibodies which recognize malignant cells from bladder carcinomas |
| WO1990014433A1 (en) | 1989-05-24 | 1990-11-29 | The University Of Sydney | Monoclonal antibodies which recognise malignant cells from bladder carcinomas |
| US7108986B2 (en) * | 1998-10-16 | 2006-09-19 | The Regents Of The University Of California | Glypican-1 in human breast cancer |
| WO2000023109A1 (en) * | 1998-10-16 | 2000-04-27 | The Regents Of The University Of California | Glypicans for the detection and treatment of human carcinoma |
| AUPR395801A0 (en) * | 2001-03-26 | 2001-04-26 | Austin Research Institute, The | Antibodies against cancer |
| US20050043273A1 (en) * | 2003-08-13 | 2005-02-24 | Margolis Richard U. | Compositions and methods for inhibiting slit protein and glypican interactions |
| PT2845866T (pt) * | 2006-10-27 | 2017-08-09 | Genentech Inc | Anticorpos e imunoconjugados e utilizações dos mesmos |
| CN104520331B (zh) * | 2012-06-01 | 2018-09-07 | 美国政府(由卫生和人类服务部的部长所代表) | 磷脂酰肌醇蛋白聚糖3的高亲和力单克隆抗体及其用途 |
| EP2981829A4 (en) * | 2013-04-01 | 2016-10-26 | Immunomedics Inc | ANTI-MUCIN ANTIBODY FOR THE EARLY RECOGNITION AND TREATMENT OF PANCREATIC CANCER |
| WO2015106311A1 (en) * | 2014-01-17 | 2015-07-23 | Minomic International Ltd. | Cell surface prostate cancer antigen for diagnosis |
| AU2014409558B2 (en) | 2014-10-23 | 2021-08-12 | Minomic International Ltd. | Monoclonal anti-GPC-1 antibodies and uses thereof |
| CN107531755B (zh) | 2015-01-16 | 2022-02-25 | 美侬米克国际有限公司 | 磷脂酰肌醇蛋白聚糖表位及其用途 |
-
2016
- 2016-04-20 AU AU2016250900A patent/AU2016250900B2/en active Active
- 2016-04-20 CA CA2983311A patent/CA2983311A1/en active Pending
- 2016-04-20 SG SG11201708624YA patent/SG11201708624YA/en unknown
- 2016-04-20 EP EP16782389.7A patent/EP3285805B1/en active Active
- 2016-04-20 CN CN201680036010.8A patent/CN107847593B/zh active Active
- 2016-04-20 KR KR1020177033428A patent/KR102739664B1/ko active Active
- 2016-04-20 US US15/567,889 patent/US11198738B2/en active Active - Reinstated
- 2016-04-20 JP JP2017555213A patent/JP7063623B2/ja active Active
- 2016-04-20 WO PCT/AU2016/000136 patent/WO2016168885A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7664357B2 (ja) | 抗ｍｅｔ抗体、ｍｅｔに結合する二重特異性抗原結合分子およびその使用方法 | |
| US12110326B2 (en) | Anti-ILT3 antibodies and antibody drug conjugates | |
| JP7401126B2 (ja) | 抗ｃｕｂドメイン含有タンパク質１（ｃｄｃｐ１）抗体、抗体薬物コンジュゲート、およびその使用方法 | |
| US20230120736A1 (en) | Anti-cd98 antibodies and antibody drug conjugates | |
| US20200338209A1 (en) | Anti-b7-h3 antibodies and antibody drug conjugates | |
| AU2019272885A1 (en) | Anti-SIRPA antibodies and methods of use thereof | |
| EP3481866B1 (en) | Combination of tim-4 antagonist and pd-1 antagonist and methods of use | |
| US20200002421A1 (en) | Anti-b7-h3 antibodies and antibody drug conjugates | |
| US11353458B2 (en) | Prognostic method | |
| JP2018517888A5 (enExample) | ||
| CA2919570A1 (en) | Diagnosis and therapy of cancer involving cancer stem cells | |
| KR20160070191A (ko) | 신규한 항-클라우딘 항체 및 사용 방법 | |
| CN111010867B (zh) | 抗双皮层蛋白样激酶1抗体及其使用方法 | |
| KR20170010764A (ko) | 신규한 항-ｒｎｆ43 항체 및 사용 방법 | |
| CN112040959A (zh) | 通过阻断vista和其结合伴侣的相互作用治疗癌症 | |
| CN110494448A (zh) | 包含抗-ly75抗体的医药组合 | |
| CN112236143A (zh) | 医药组合 | |
| HK40027735A (en) | Anti-doublecortin-like kinase 1 antibodies and methods of use | |
| HK40027735B (en) | Anti-doublecortin-like kinase 1 antibodies and methods of use |